Fig. 1

Recommended next step (PET excluded) in a the independent cohorts, and b the pre–post cohort. a Comparing two independent cohorts, there was a significantly higher rate of choice of surgical resection or other ablative therapy with a Percepta GSC very high risk result (1st column) compared to the cohort without a Percepta GSC very high risk result (2nd column) (p < 0.0001). b In the pre–post cohort, providing a Percepta GSC very high risk result significantly increased the rate of choice of surgical resection or other ablative therapy p < 0.0001)